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Abstract. The skin, the conjunctivae, the airways and the
digestive tract compose a huge vulnerable biological surface,
which is exposed to the external environment. An allergen can
often trigger an allergic reaction at a number of sites or result
in an atopic march. However, the mechanism of atopic march
remains unclear. Less attention has been paid to the connection
between the primary site and the atopic site, because current
knowledge is established directly against harmful factors.
Allergic hypersensitivity manifests in parts of the human
body far away from the allergen. Growing evidence suggests
that the epithelial cells serve as the ‘engine’ which initiates
an allergic reaction through the production of large quantities
of cytokines, chemokines and growth factors. Because the
epithelial cells cover the entire surface of the skin, the
conjunctivae, the airways, and the digestive tract, and are
positioned at the terminals of neurons and the blood supply,
the connection between the primary site and the atopic site can
not be easily understood by the current knowledge of anatomy
and of the neuroendocrine immune network. What is the
linkage between these huge vulnerable biologic surfaces? This
article highlights selected frontiers in allergy research of
atopic march, and focuses on recently attained insights into
the cellular and molecular events of primary and atopic lesions
in the allergy progress. Special attention is paid to the homo-
geneity of the cellular and molecular events on the huge
vulnerable surface. Based on currently available data we
conclude that the skin, conjunctivae, airways and digestive
tract may join together to form the frontier ‘commonwealth
union’ in order to fight the allergen. The epithelial cells are
the ‘engine’ as well as the main target which initiates both
primary and atopic inflammatory reactions. The atopic lesion
may ‘duplicate’ the primary contacted site of cellular and
molecular events. The atopic march may be due to the intrinsic
‘social’ involvements of the positioned epithelial cells, but
may not be totally controlled by the anatomic connection or
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1. Introduction
Allergic diseases affect approximately one-third of the
population and constitute one of the major health care problem
in the Western world (1,2). Allergy is an inappropriate
inflammatory reaction to an antigen. The allergen triggers an
exaggerated immune response, and can aggravate an allergic
response on the entire surface of the skin, the conjunctivae,
the airways and the digestive tract (3-5). The entire surface of
the skin, conjunctivae, airways and of the digestive tract has
been activated to fight allergens, although most of them are
not directly exposed to the harmful factor. The skin,
conjunctivae, airways and the digestive tract may form a
‘commonwealth union’ to fight allergens anywhere on the
huge vulnerable biologic surface. The communication among
the surface ‘commonwealth union’ has been clinically
documented during immediate allergic reactions or atopic
march events. An inflammatory reaction is a protective
response against the harmful factors; an atopic inflammatory
reaction may indicate a close relationship between the
primary site and atopic sites in the pathogenesis of an allergy
(6-9). Although more and more information is accumulating
about the molecular events mediating a series of cellular
events such as activation, degeneration, apoptosis, necrosis,
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differentiation, hyperplasia, carcinogenesis and inflammation
caused by the direct harmful factor exposure, there is still
not enough knowledge to understand the intrinsically distal
communication. It still remains unknown why in an allergic
reaction there are homogeneous cellular and molecular
events which take place not only at the primary-contacted
site of the airways, skin or digestive tract but also to the not
directly exposure distal sites, and there can even be a whole
body response. What is the mechanism of the immediate
atopic allergic reaction or atopic march? In this article, we
we provide an overview of the cellular and molecular events
with a special emphasis on the homogeneity between the
primary contacted sites and the secondary ‘passive’ inflam-
matory response sites of the systemic allergic involvements.
This phenomenon is not easily understood by current
knowledge of anatomy and the neuroendocrine immune
network. To the best of our knowledge, in the allergy
pathogenesis, the homogeneous cellular and molecular
inflammatory events take place at the directly-exposed sites
and the not directly-exposed atopic sites. The allergen-
mediated homogeneous cellular and molecular events may be
initiated by cytokines or chemokines produced by local
epithelial cells, but may not be totally controlled by an
anatomic connection or circulating systemic factor
mediation. An allergen may trigger the ‘social manner’ of
cells and molecules in allergy pathogenesis. The indirectly-
exposed sites may ‘duplicate’ the ‘social’ inflammatory
reaction of the directly-exposed site.
Our body is a highly ordered organ system. The commu-
nication among the organs such as the lung and the colon is a
clinically-observable event (10-12). The organ is not a
mixture of a bunch of cells and molecules. We hypothesize
that each individual cell or molecule not only plays its local
role in the positioned organ, but may also play a ‘social’ role
on the distal communication during exposure to harmful
factors (11,13-14). In fact, the ‘social property’ of cells and
molecules is a clinically-documented event (13,14). The
entire surface of the skin, the conjunctivae, the airways and
the digestive tract may be intrinsically involved in a ‘social’
inflammatory reaction to fight allergens. In the allergic
pathogenesis, although cells of the epithelium, mast cells, T
helper 2 (Th2) lymphocytes and the molecules of immuno-
globulin E (IgE), chemokines and cytokines are located in
different parts of the body, they may ‘socially’ respond in the
systemic involvements of allergy. The indirectly-exposed
sites of the skin, the conjunctivae and of the respiratory,
alimentary, or reproductive tracts and even of some solid
organs may form a huge ‘commonwealth union’ which
‘socially’ responds and contributes to the pathogenesis of a
distal allergic reaction.
2. The surface of the skin, the conjunctivae, the airways
and the digestive tract may be a ‘commonwealth
union’
The skin, the conjunctivae, the airways, and the digestive
tract have all been implicated in the systemic involvements
of allergy. The entire surface of the skin, the conjunctivae,
the airways, and the digestive tract may form a clinically-
observable ‘commonwealth union’.
Allergen sensitization and challenge in the skin and the
systemic response. When a patient gets in contact with latex,
an allergic reaction may occur immediately or develop later
(15-19). The symptoms of the reaction include hives and
urticaria. The skin reaction may occur anywhere in the body
and not necessarily at the site where the direct contact with
the latex occurred (15,16). In the meanwhile, an allergic
reaction may occur at the conjunctivae, airways and digestive
tract even at the whole body. The symptoms of this allergic
reaction include wheezing; coughing; shortness of breath;
sneezing; nasal congestion; runny nose; conjunctivitis (red,
itchy, watery eyes); nasal, palatal, or ocular itching; naso-
rhinitis (chronic runny nose); asthma; hypertension; and
anaphylaxis, a serious and potentially life-threatening allergic
response. The latex-triggered hypersensitivity reaction may
affect the entire surface of the skin, the conjunctivae, the
airways and the digestive tract (15-19). Obviously, there is a
clinically-observable connection between the skin, and the
conjunctivae, airways and the digestive tract. A latex allergy
has often been associated wtih the presence of a concomitant
food allergy (19).
Allergen sensitization and challenge in the digestive tract and
the systemic response. Similarly, in food-mediated allergy,
the food hapten may also trigger an exaggerated inflam-
matory reaction on all the members of this ‘commonwealth
union’, and cause itching; scratchy throat; hives anywhere on
the body; swelling of the eyelids, face, or tongue; nausea;
cramps; vomiting; diarrhea; nasal congestion; shortness of
breath or wheezing (20-24). When the blood pressure drops
down, the airways are blocked, and the throat is closed, the
reaction can be serious and potentially life-threatening and
can eventually progress into anaphylaxis (20-24). Therefore,
there is a clinically-observable connection between the
digestive tract and the skin, conjunctivae, and airways.
Allergen sensitization and challenge in the airways and the
systemic response. When a patient inhales pollen, pollinosis
is not limited to rhinoconjunctivitis and/or bronchial asthma,
but may intrinsically extend to an inflammation of the
digestive tract and the skin (25-27). The symptoms of the
reaction are very similar to latex contact and food allergy (27).
The connection between the airways and the conjunctivae,
the skin and the digestive tract is a clinically-observable event
in the pathogenesis of pollinosis.
Latex allergen, food protein and the airways source of
pollen and house mites, all may aggravate an inflammatory
reaction on entire surface of the skin, conjunctivae, airways
and of the digestive tract although most of them are not sites
of direct hapten exposure. These symptoms of latex allergy
can be exacerbated in certain people when specific foods,
such as hevamine-containing fruits, are ingested (19). Food
allergy and asthma commonly co-exist in the same patient
(20,27). Approximately one-third of children with a food
allergy have asthma, and 4-8% of children with asthma have
food allergies (20). As mentioned before, allergic diseases
typically develop on the entire mucosal surface of this
‘commonwealth union’. The allergic inflammatory reaction
site may not be in direct contact with the allergen. The
directly-contacted allergen site can drive an allergic inflam-
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mation anywhere on the surface of this ‘commonwealth
union’. The allergen can elicit an inflammatory reaction on
all the members of the ‘commonwealth union’ regardless of
the primary-contacted site (Fig. 1).
3. The epithelial cells are the initial and main target of
the organ involved in the allergy pathogenesis
The entire surface of the skin, conjunctivae, airways and
digestive tract forms a clinically-observable ‘commonwealth
union’ during the systemic involvement of allergy. The
epithelial cells cover the entire mucosal surface of the
‘commonwealth union’. More and more evidence is accumu-
lating that the epithelial cells could be considered not only the
frontier sentinels and barriers, but also the central participants
in the innate and adaptive immune responses as well as in
mucosal inflammation. The epithelial cells can release large
quantities of proinflammatory cytokines, growth factors and
chemokines that attract inflammatory cells to initiate and
sustain an inflammatory reaction (28-32). The epithelial cells
of the entire surface of the skin, the conjunctivae, the airways
and the digestive tract are also the main targets during the
pathogenesis of the systemic involvement of allergy (Fig. 2).
The epidermal keratinocyte is the initial and main target of
the allergic skin involvement. The skin, which covers the
entire body, is continuously exposed to the external environ-
ment. It serves as a protective barrier: microorganisms find it
almost impossible to traverse the epidermis, and water loss is
inhibited. The skin has the potential to provide a window into
the patient and aid in the diagnosis of diseases of all organ
systems. Disorders of every organ may cause skin symptoms
and signs (33). Physicians of Traditional Chinese Medicine
(TCM) believe that skin is a ‘Biao’ (surface) which always
relates to disorders of the ‘Li's’ (internal organs). The skin may
be the favorable and easiest observable organ for studying
the pathogenesis of the systemic involvement of allergy,
because during the allergic progress it always elicits an
inflammatory reaction even though the primary allergen
contact site is located in the skin, airways or digestive tract.
Allergic skin disorders include urticaria, angioedema,
contact dermatitis and atopic dermatitis (AD) (34). Contact
dermatitis is a localized rash or irritation of the skin caused
by contact with a foreign substance. Inflammation of the
affected tissue is present in the epidermis and dermis where
direct contact with the hapten takes place (34). Urticaria,
angioedema, and AD are atopic disorders, in which contact
of a specific allergen with the surface of the gastrointestinal
or the respiratory tract drives an allergic reaction from the
primary allergen contacted sites to the skin (30,34). Urticaria
and angioedema are wheals, characterized by central
swelling surrounded by erythema, associated with itching. In
the inflammatory process, both the dermis and the subcutis
are involved, but the main target is the epidermis (30,34). AD
is characterized by eczematous changes in the epidermis, and
most patients have an atopic background with past or family
histories of bronchial asthma, allergic rhinitis, and/or allergic
conjunctivitis. Infiltration of lymphoid cells into the epidermis
and upper dermis can be observed under the microscope (34).
The epidermal keratinocytes, which are triggers of immune
abnormalities, as well as peripheral effectors, are important
to further disclose the pathogenesis of this enigmatic disorder
(29,30,34). Although the involved layer is different in
individual cases of allergic skin diseases, the keratinocytes
which produce cytokines and chemokines have been consid-
ered as the crucial factors in the initiation of skin inflammation
(29,30,24). Therefore, the epidermal keratinocytes are
believed to be the ‘engine’ initiating skin inflammation. The
epidermal keratinocytes are also believed to be the main
target of eczema and the key participants in the allergic skin
disorders (29,30). Because the epidermal keratinocytes are
positioned at the first line to fight harmful factors, it would
be easy to postulate that allergens drive these cells to release
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Figure 2. Model summarizing the epithelial cells as an ‘engine’ to initiate an
allergic reaction and main target in allergy pathogenesis. The epithelial cells
cover the surface of the skin, conjunctivae, airways and digestive tract, and
are the first in line to fight allergens. The epithelial cells are the central
participants of the innate recognition, polarization of inflammatory cells,
and initiation of adaptive immunity through cytokines and chemokines. On
the other hand, the mesenchymal inflammatory cells target the epithelial
cells.
Figure 1. Model for allergens triggering the entire surface of allergic
reactions. Allergens such as latex, food hapten, pollen or house mites may
contact any site(s) on the surface of the skin, the conjunctivae, the airways
and of the digestive tract, aggravating the entire surface and resulting in an
immediate allergic reaction or a late-developed atopic march. The skin,
conjunctivae, airways and digestive tract join a huge ‘commonwealth union’
to fight allergens. Allergic hypersensitivity manifests in parts of the body
which are not in direct contact with the allergens.
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cytokines and chemokines and to polarize the inflammatory
cells under exposure. If there are no allergens contacting the
surface of the skin, why are the epidermal keratinocytes still
producing cytokines and chemokines and polarizing the
inflammatory cells? There should be a communication
among the epidermal keratinocytes and the airway epithelial
cells, digestive tract and conjunctivae. In fact, a latex-
mediated allergic reaction may occur anywhere in the body
and not necessarily at the site where direct contact with the
latex occurred. So there also should be a communication
between the epidermal keratinocytes of the latex-contacted
site and the epidermal keratinocytes of the site not directly
contacted by latex.
The airway epithelium is the initial main target in allergy. The
airway epithelial cells, which are at the first line of exposure to
many pathogens, serve as a complex physical barrier that
defends against exposures to potentially harmful inhaled
substances and microbial pathogens. A breakthrough in the
understanding of the ability of the innate immune system to
rapidly recognize pathogens occurred with the discovery of the
Toll-like receptors (TLRs). TLRs were originally identified as
homologues of Drosophila Toll. To date, 10 human TLRs
have been identified (35-37). Airway epithelial cells express
mainly TLR2-6, which plays a crucial role on the innate
immune recognition (28,32,38,39). TLR signaling can lead to
activation of several transcription factors such as NF-κB, and
interferon (IFN) regulatory factors (IRF) 3, 5 and 7. The
activation of NF-κB induces proinflammatory genes such as
TNF, interleukin (IL)-6 and IL-12 expression (28).
Activated airway epithelial cells can induce the synthesis
and secretion of immune cell-mediated host defense molecules
(28,40), which result in an immediate host defense. Host
defense molecules such as antimicrobial and antiviral
proteins belong to proinflammatory cytokines which can
activate other mucosal innate immune cells. The major
antimicrobial products secreted constitutively or inducibly by
epithelial cells include lysozyme, lactoferrin, defensins,
collectins, pentraxins, LL-37, the secretory leukocyte protease
inhibitor and serum amyloid A (40). In the allergic inflam-
matory reaction, the activation of Th2 cells and secretion of
IL-4, IL-5, and IL-13 is linked with an impaired antibacterial
response (28).
Activated innate immune responses can secondarily
induce the recruitment and activation of dendritic cells (DCs)
that amplify antigen recognition, antibody production and
other adaptive immunity (28,32,38-40). Epithelial DCs are
recruited from the blood. Airway epithelial cells are capable
of inducing migration of DCs into the epithelium via CCL20
(MIP-3·) production (41). Epithelial cells in collaboration
with lymphocytes contribute to the recruitment and the
differentiation of DCs from circulating monocytes. The
process of attraction and differentiation of monocytes is
driven by pulmonary epithelial cells, Th2 cells, natural killer
(NK) cells or basophils (28). The GM-CSF and IL-15 from
the pulmonary epithelial cells are important factors in this
process (28). Epithelial cells may enhance an allergic airway
inflammation by inducing DC-mediated Th2 differentiation
and also increase mast cell activation via the production of
thymic stromal lymphopoietin (TSLP) (9,28,32).
Activated innate immune responses can also secondarily
induce recruitment and activation of T, and B lymphocytes
that amplify antigen recognition, antibody production and
other adaptive immunity (9,28,32,38-40). Local T lymphocyte
responses and immunoglobulin production are quite important
both for the protection from pathogens and in the pathogenesis
of various types of inflammatory diseases of the airways
(9,32). Therefore, the epithelial cells are the central parti-
cipants in the regulation of both the innate and the adaptive
immune responses in airway inflammation (32). Most of
asthma patients exhibit a Th2 inflammatory response with
coordinated up-regulation of cytokines produced by epithelial
cells; however, over-interpretation of the immunologic path-
way has led to a simplistic view that asthma results purely
from allergen sensitization and exposure (32). Allergens can
break tissue homeostasis and dysregulate the local tissue
microenvironment. The aberrant epithelial injury/repairs
were believed as the mechanism of allergic inflammation of
the airways (9,28,32,38-40).
Skin contacted latex allergen, food protein, and the airways
source of pollen and house mites, all can exacerbate the
whole airway inflammatory reaction. Bronchial asthma is a
common chronic disorder of the airways characterized by
bronchial hyperresponsiveness, airflow obstruction and an
underlying inflammation which affects about 7% of the
population in the United States (20). Bronchial asthma
frequently accompanies AD, allergic rhinitis, and allergic
conjunctivitis (20). More and more evidence is accumulating
that both the skin epidermal keratinocytes and the airway
epithelial cells are the initial main target of the inflammatory
reaction (9). Less attention has been paid to the epithelial
cells of the digestive tract. These cells may behave like the
epidermal keratinocytes of the skin and the airway epithelial
cells. The epithelial cells produce cytokines and chemokines,
and drive the inflammatory cell polarization. Viewing asthma
primarily as an epithelial disease with adoption of a chronic
wound scenario also provides a route to the airways wall
remodeling and asthma phenotypes varying over the course
of life (32). The mechanism should be either the systemic,
factor-mediated cellular and molecular events or the intrinsic
connection between the primary and the atopic sites. As is
known, the epithelial cells are located at the terminals of the
neurons and the blood supply. Therefore, the systemic factor-
mediated connection is not easy to be totally understood by
the current knowledge of anatomy, and of the neuroendocrine
immune network. These cellular and molecular events may
relate to the intrinsic ‘social manner’ of cells and molecules.
4. The ‘social manner’ of cells and molecules
In the allergy pathogenesis, the surface of the skin, conjunc-
tivae, airways, and digestive tract has been involved in the
inflammatory reaction to fight allergens. They may form a
huge ‘commonwealth union’ against the allergen. What are
the cellular and molecular events taking place in the huge
‘commonwealth union’?
The linkage of epithelial cells in different sites may be through
an intrinsic ‘social’ involvement and not by systemic factor
mediation. Atopic diseases include eczema (AD), asthma,
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allergic rhinitis, etc. AD is often the initial step in the atopic
march; up to 70% of patients with severe AD develop asthma
later in life (7,42,43). AD and asthma share an atopic
phenotype that includes Th2 inflammation with eosinophilia
and hyper-IgE immunoglobulinemia. However, the molecular
mechanisms underlying the atopic march remain unclear
(7,9,32,42,43). More and more evidence has been accumu-
lating that the epithelial cells are the key participants, which
initiate allergic inflammation, as well as the main targets in
the pathogenesis of allergy. Activated epithelial cells may
produce large quantities of proinflammatory cytokines and
chemokines which drive inflammatory cell polarization, and
elicit inflammation. Recently, TSLP, a general biomarker for
skin-barrier defects (7,9,32) and an IL-7-like cytokine
produced by epithelial cells, emerged as a potential master
regulator of both skin and the airways inflammation (7,9,32).
TSLP signaling plays an important role in the allergic airway
and skin inflammation. Zhang et al (9) found that increased
TSLP expression in skin keratinocytes not only locally
triggered AD-like lesions in the skin of mice, but also lead to
an aggravation of a concomitant ovalbumin (OVA)-induced
asthma-like lung inflammation (Fig. 3). Furthermore, Zhang
et al elucidated that an increased TSLP expression in
epidermal keratinocytes and the subsequent increase in
blood circulating TSLP in their mouse model did not lead to
spontaneous lung inflammation in the absence of OVA
sensitization and challenge (9). In fact, there are high TSLP
mRNA expression levels in bronchial epithelial cells and in
the submucosa of asthmatic patients (44), which indicate that
TSLP locally produced in the lung could be important in the
development and/or maintenance of asthma. We may conclude
that TSLP is a crucial factor driving both the skin and the lung
into inflammation. However, an increased TSLP expression
in epidermal keratinocytes and a subsequent increase in
blood circulating TSLP are not enough to drive both the skin
and the lung into inflammation (9). Obviously, the lung
inflammatory reaction is not triggered by circulating TSLP,
and it may be produced by the pulmonary epithelial cells
themselves. Since the epithelium is on the terminal of the
blood supply, an atopic allergic response, especially an
immediate allergic response is not easy to be understood by
current knowledge of anatomy. OVA sensitization and
challenge are extremely important to drive both the skin and
the lung into inflammation. The intrinsic connection between
the skin and the lung may be through locally produced TSLP
underlying OVA sensitization and challenge. This intrinsic
communication among heterogeneous epidermal keratino-
cytes and airway epithelial cells may relate to the ‘social
manner’ of epithelial cells. Allergens, such as OVA, trigger
this potential ‘social property’ of the epithelial cells (Fig. 3).
The ‘social manner’ of cells and molecules in allergy
pathogenesis. In the allergy pathogenesis, allergens such as
OVA drive both the skin and the lung into inflammation.
Allergens are a crucial factor connecting skin epidermal
keratinocytes and lung epithelial cells. Cytokines and chemo-
kines, such as TSLP, released from activated epithelial cells
break the local microenvironment and the tissue homeostasis
of the epithelial-mesenchymal trophic unit and trigger the
inflammatory reaction (32,45). The epithelial cell-mediated
inflammatory cellular and molecular events have been
extensively studied and well established. The inflammatory
reaction occuring at the huge vulnerable biological surface is
a bunch of homogeneous cellular and molecular events. Mast
cells are key cells in the pathogenesis of IgE-dependent
hypersensitivity reactions (46). Mast cells are connective
tissue cells which are widely distributed throughout the body
predominantly near blood vessels and nerves (46). Evidence
is accumulating that allergens trigger mast cell activation
through the epithelial cells (30,46). It is very difficult to
understand the mechanism of the mast cell-mediated allergic
reaction, especially the immediate atopic allergic reaction
through the systemic factors from the blood or nerves. Mast
cells and IgE molecules may be intrinsically activated
through allergen-mediated epithelial cells. Both bronchial
asthma and AD are characterized by Th2-mediated chronic
inflammatory diseases in response to allergen (7,9,32,34).
Locally-produced but not circulating TSLP has been
postulated to be a master regulator of Th2 inflammation with
eosinophilia and hyper-IgE immunoglobulinemia (9). In
accordance, most of atopic cellular and molecular events are
induced by the locally-produced initial regulators and not by
circulating regulators. The majority of locally produced
initial regulators come from allergen-activated epithelial cells
(9,32). An allergic disorder may be an epithelial disease with
adoption of a wound scenario (32). The manner in which
circulating regulators directly contact the allergen may relate
to the ‘social property’ of cells and molecules. Therefore, the
homogeneous cellular and molecular events of an immediate
atopic allergic reaction and/or the atopic march may relate to
the dysfunction of the ‘social manner’ of cells and molecules.
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Figure 3. Model summarizing how ovalbumin drives the skin and lung into
inflammation. This figure shows ovalbumin driving both the skin and the
lung into inflammation. Part A shows atopic dermatitis-like lesion of the
skin, in which TSLP over-production by the epidermal keratinocytes
underlies the ovalbumin sensitization and challenge. Part B shows an asthma-
like lesion of lung, in which epithelial cells overproduce TSLP underlying
the ovalbumin sensitization and challenge. The ovalbumin sensitization and
challenge are crucial factors driving both the skin and lung into inflam-
mation. The relationship between part A and part B may be through an
intrinsic ‘social’ connection of the epidermal keratinocytes of the skin and
the epithelial cells of the lung, but may not be through the circulating TSLP
from epidermal keratinocytes targeting epithelial cells of the lung.
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5. Possible evidence of the ‘social manner’ of cells and 
molecules
The skin, conjunctivae, airways, digestive and reproductive
tract is a huge vulnerable biological surface, which is
continuously exposed to the environment. The epithelial cells
cover the entire surface, and are the first line to fight any
possible harmful factors. The epithelial cells play a crucial
role in the innate immune recognition, the host defense. The
direct or indirect interaction of epithelial cells with mast
cells, T, and B lymphocytes, DCs, eosinophils, neutrophils,
and basophils has been extensively studied and well docu-
mented (28). The epithelial cells on the entire surface form a
‘commonwealth union’ and intrinsically respond to harmful
factors such as allergens. The ‘social manner’ of cells and
molecules is a useful paradigm to describe the intrinsically
distal communication.
Filaggrin and atopic march. Filaggrin as a major predisposing
gene for atopic disease has caused a major paradigm shift in
dermatology and allergy research (47). Filaggrin is a skin
barrier protein in the granular layer of the epidermis and
aggregates keratin filaments in the cell to form the cornified
envelope, which is critical for maintaining an effective skin
barrier against the environment (20,47,48). Recent human
genetic studies strongly suggest that perturbation of the skin
barrier function as a result of reduction or complete loss of
filaggrin expression leads to enhanced percutaneous transfer
of an allergen (47-49). The expression level of filaggrin has
been known to be decreased in AD patients at both the
protein and mRNA levels (50,51). The filaggrin gene defect
may be the foundational predisposing factor not only for the
development of eczema, but also for the initial sensitization
and progression of the allergic diseases (47,48). AD patients
with filaggrin loss-of-function mutation exhibit an increased
incidence of asthma (52). In fact, filaggrin gene expression is
limited to the skin and the oral mucosa and is absent in the
epithelial cells of the upper and lower airways, and digestive
tract (47,53). The loss-of-function mutation of the filaggrin
gene is not only directly involved in dysfunction of the skin
barrier, but is also indirectly involved in barrier dysfunction
of the upper and lower airways and of the digestive tract
(54). The mechanism by which the dysfunction of the skin
barrier leads to the atopic march of the airways and the
digestive tract remains unknown. The atopic march underlying
the loss-of-function mutation of filaggrin may break the
‘social’ connection of the ‘commonwealth union’.
In conclusion, allergic hypersensitivity manifests in parts
of the human body which are not in direct contact with the
allergen. Allergic reaction is an epithelial cell-mediated
inflammation. The connection between the skin, conjunctivae,
airways and the digestive tract may relate to the ‘social
manner’ of the cells and molecules.
In human beings, the organs, cells and molecules are
‘social’ members of the body (11,13,14). This is a plausible
hypothesis. For example, a latex-mediated allergic reaction
may occur anywhere in the body or the skin and not neces-
sarily at the site of direct contact with latex. How can current
knowledge of anatomy, and neuroendocrine immunity provide
evidence of the connection between the latex contacted site
and the non-contacted site? The concept of the ‘social
manner’ of cells and molecules would be a plausible concept
to understand the atopic march and to gain knowledge on the
cellular and molecular mechanisms of TCM. The physicians
of TCM believe that the body is an open system. The TCM
physician will first carefully examine the patients' skin;
tongue and conjunctivae then proceed to further examination
and make a diagnosis. The skin, tongue and conjunctivae are
believed as a ‘Biao’ (surface) which always relates to
disorders of the ‘Li's’ (internal organs). In the allergy patho-
genesis, the allergen as a ‘social’ factor drives the epithelial
cells of the skin, conjunctivae, airways and digestive tract
into inflammation. The ‘social manner’ of cells and
molecules could also help to attain insight into the patho-
genesis of enigmatic complications such as inflammatory
bowel diseases (IBD). For example, patients with chronic
IBD (chronic ulcerative colitis and Crohn's disease) may
have a variety of extraintestinal manifestations, including
arthritis, ankylosing spondylitis, erythema nodosum, pyoderma
gangrenosum, dermatitis, aphthous stomatitis, conjunctivitis,
episcleritis, uveitis, hepatitis, pericholangitis, sclerosing
cholangitis, primary biliary cirrhosis, pancreatitis, thyroiditis,
pyelitis, and pericarditis (10-12). There are homogeneous
inflammatory cellular and molecular events taking place in
all of the involved organs. The complications of IBD may
relate to a dysfunction of the ‘social manner’ of inflammatory
cells and molecules due to the inflammatory cells and
molecules present in all the involved organs.
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